Fernanda Dias

Dr. Fernanda Dias

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
FDFernanda Dias
Fernanda Dias
SMSérgio L.P. Matta
Sérgio L.P. Matta
GLGraziela D.A. Lima
Graziela D.A. Lima
ASAna Cláudia Ferreira Souza
Ana Cláudia Ferreira Souza
TMTatiana Prata Menezes
Tatiana Prata Menezes
MGMarcos Lucca Moreira Gomes
Marcos Lucca Moreira Gomes

1 January 2025 in Brazilian Journal of Biology
Verified
Journal Article
Open access
PDF file
JLJ. V. Lopes-Ferreira
J. V. Lopes-Ferreira
JMJ. E. M. Matos
J. E. M. Matos
FDFernanda Dias
Fernanda Dias
GSG. E. M. L. Siervo
G. E. M. L. Siervo
MGMarcos Lucca Moreira Gomes
Marcos Lucca Moreira Gomes
Infertility is a global health issue and is closely related to oxidative stress, which occurs when high concentrations of free radicals surpass the protective effects of antioxidant molecules and enzymes. Such imbalance causes damage to DNA, as well as cellular proteins and lipids, ultimately leading to the destruction of the blood-testis barrier. This, in turn, hinders spermatogenesis. Various plants and compounds have been employed in an attempt to reverse these damages, such as phenolic compounds. Therefore, this review aims to identify the main phytochemical phenolic compounds and their respective effects when used in the treatment of male infertility. Related information concerning phenolic phytochemical compounds was gathered from studies selected from PubMed, Scopus, and Web of Science databases. The search was conducted using the combination of six terms: “phenolic compounds”, “male infertility”, “testis”, “spermatozoa”, “testosterone” and “male fertility”. These compounds can raise testosterone levels, reduce lipid peroxidation, and improve tubular histoarchitecture in cases of subfertility associated with diabetes mellitus. They can also mitigate the damage caused by obesity by increasing serum testosterone, antioxidant activity, and sperm motility. When it comes to fertility problems caused by inorganic and organic pollutants, these compounds effectively restore the structure of the seminiferous tubules, increase testosterone levels, and improve sperm quality. Furthermore, phenolic phytochemical compounds have shown beneficial effects in countering the adverse impacts of certain drugs on testicular physiology by reducing apoptosis in testicular tissue, increasing the number of Leydig cells, and promoting spermatocyte production. However, while these compounds may have protective effects on sperm cryopreservation for in vitro fertilization, caution is needed as certain dosages can cause irreversible damage to sperm quality. Overall, plant extracts containing phenolic phytochemical compounds hold promise as a therapeutic avenue for treating infertility and subfertility caused by metabolic disorders and environmental pollutants.

1 February 2014 in Pesquisa Agropecuária Brasileira
Verified
Journal Article
Open access
PDF file
EAEmmanuelle Rodrigues Araújo
Emmanuelle Rodrigues Araújo
WHWolfgang Harand
Wolfgang Harand
ILIwanne Coelho Lima
Iwanne Coelho Lima
FDFernanda Dias
Fernanda Dias
ASAdelmo Adriane Duarte de Santana
Adelmo Adriane Duarte de Santana
DLDelson Laranjeira
Delson Laranjeira
O objetivo deste trabalho foi avaliar o efeito de extratos de capeba (Piper marginatum) e nim (Azadirachta indica) sobre o fungo Colletotrichum scovillei e determinar o componente mais ativo no controle pós-colheita da antracnose em pimentão. A atividade de extratos metanólicos das folhas (P. marginatum e A. indica) e das sementes (A. indica) a 0, 125, 250, 500, 1.000 e 2.000 ppm, na inibição do crescimento micelial de C. scovillei in vitro foram avaliadas. O extrato metanólico de folhas de P. marginatum foi o mais ativo e, consequentemente, foi submetido ao fracionamento biomonitorado ("bioassay-guided fractionation"). Esse processo rendeu 10 frações majoritárias, obtidas por cromatografia líquida de alta performance, das quais a fração à concentração de 1,5 ppm inibiu o desenvolvimento de C. scovillei de forma mais eficiente do que o fungicida mancozeb.

Verified
Journal Article
Open access
PDF file
VLVitória Louise
Vitória Louise
BMBianca Alves Almeida Machado
Bianca Alves Almeida Machado
WPWashington Martins Pontes
Washington Martins Pontes
TMTatiana Prata Menezes
Tatiana Prata Menezes
FDFernanda Dias
Fernanda Dias
Andre TalvaniAndre Talvani
Andre Talvani
Theracurmin is a nanoparticle formulation derived from curcumin, a bioactive compound known for its antioxidant and anti-inflammatory properties. Trypanosoma cruzi, the etiological agent of Chagas disease, triggers an intense inflammatory response in mammals and also causes severe tissue damage. To evaluate the immunomodulatory and antiparasitic effects of Theracurmin, Swiss mice were experimentally infected with 103 trypomastigote forms of the Colombian strain of T. cruzi and submitted to daily therapy with 30 mg/kg of Theracurmin. In addition, daily benznidazole therapy (100 mg/kg) was performed as a positive control. We evaluated the systemic and tissue parasitism, the survival and the body mass rate, the release of inflammatory mediators (TNF, IL-6, IL-15, CCL2 and creatine kinase) and the tissue inflammation at day 30 post-infection. Theracurmin therapy reduced the parasitemia curve without altering the animals’ survival rate, and it protected mice from losing body mass. Theracurmin also reduced CCL2 in cardiac tissue, IL-15 in cardiac and skeletal tissue, and plasma CK. Even without effects on TNF and IL-6 production and tissue amastigote nests, Theracurmin reduced the leukocyte infiltrate in both evaluated tissues, even in the case of more effective results observed to the benznidazole treatment. Our data suggest Theracurmin has an immunomodulatory (CCL2, IL-15, CK and tissue leukocyte infiltration) and a trypanocidal effect (on circulating parasites) during experimental infection triggered by the Colombian strain of T. cruzi. Further investigations are necessary to comprehend the Theracurmin role performed in combination with benznidazole or other potential anti-T. cruzi chemical compounds.

Verified
Journal Article
Open access
PDF file
HPHelen F. M. Pacheco
Helen F. M. Pacheco
JFJhessyka L. F. Fernandes
Jhessyka L. F. Fernandes
FDFernanda Dias
Fernanda Dias
MDMarina C. Deus
Marina C. Deus
DRDaniele L. Ribeiro
Daniele L. Ribeiro
MGMarcos Lucca Moreira Gomes
Marcos Lucca Moreira Gomes
(1) The primary prostate cancer treatment involves androgen deprivation therapy, with or without chemotherapy. Immunotherapy has emerged as a promising strategy against cancer due to its ability to modulate the immune system, overcome immune evasion, and stimulate the attack on tumor cells. Thus, this review urges an exploration of the underlying mechanisms to validate the efficacy and safety of dendritic cell immunotherapy for prostate cancer treatment. (2) An extensive literature search identified 45 eligible studies in PubMed, Web of Science, SCOPUS, and Embase databases. Phase I and II clinical trials and in vitro studies (PROSPERO registration number CRD42024538296) were analyzed to extract information on patient selection, vaccine preparation, treatment details, and disease progression. (3) Despite significant variability in vaccine development and treatment protocols, vaccines were shown to induce satisfactory immune responses, including T-cell activation, increased CD4 and CD8 cell populations, upregulated expression of HLA-A2 and HLA-DR, enhanced migratory capacity of dendritic cells, and elevated interferon levels. Cytokine responses, particularly involving Interleukin 10 (IL-10) and Interleukin 12 (IL-12), varied across studies. Immunotherapy demonstrated potential by eliciting positive immune responses, reducing PSA levels, and showing an acceptable safety profile. However, side effects such as erythema and fever were observed. (4) The analyzed treatments were well-tolerated, but variability in clinical responses and side effects underscores the need for further research to optimize the efficacy and safety of this therapeutic approach.

22 December 2023 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Closed access
GQGian Carlo D.´aNgelo de Queiroz
Gian Carlo D.´aNgelo de Queiroz
FDFernanda Dias
Fernanda Dias
STSandra Maria de Torres
Sandra Maria de Torres
MPMárcia de Figueiredo Pereira
Márcia de Figueiredo Pereira
DMDanielle Barbosa Morais
Danielle Barbosa Morais
VJValdemiro Amaro de Silva Junior
Valdemiro Amaro de Silva Junior